Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150(3699):971–9.
Hillman P, Wall PD. Inhibitory and excitatory factors influencing the receptive fields of lamina 5 spinal cord cells. Exp Brain Res. 1969;9(4):284–306.
Kapural L, Yu C, Doust MW, Gliner BE, Vallejo R, Sitzman BT, et al. Novel 10-kHz high-frequency therapy (HF10 therapy) is superior to traditional low-frequency spinal cord stimulation for the treatment of chronic back and leg pain: the SENZA-RCT randomized controlled trial. Anesthesiology. 2015;123(4):851–60.
Deer T, Slavin KV, Amirdelfan K, North RB, Burton AW, Yearwood TL, et al. Success using neuromodulation with BURST (SUNBURST) study: results from a prospective, randomized controlled trial using a novel burst waveform. Neuromodulation. 2018;21(1):56–66.
Deer TR, Patterson DG, Baksh J, Pope JE, Mehta P, Raza A, et al. Novel intermittent dosing burst paradigm in spinal cord stimulation. Neuromodulation. 2021;24(3):566–73.
Vesper J, Slotty P, Schu S, Poeggel-Kraemer K, Littges H, Van Looy P, et al. Burst SCS microdosing is as efficacious as standard burst SCS in treating chronic back and leg pain: results from a randomized controlled trial. Neuromodulation. 2019;22(2):190–3.
Leong SL, De Ridder D, Deer T, Vanneste S. Potential therapeutic effect of low amplitude burst spinal cord stimulation on pain. Neuromodulation. 2021;24(3):574–80.
Provenzano D, Tate J, Gupta M, Yu C, Verrills P, Guirguis M, et al. Pulse dosing of 10-kHz paresthesia-independent spinal cord stimulation provides the same efficacy with substantial reduction of device recharge time. Pain Med. 2022;23(1):152–63.
Thomson SJ, Tavakkolizadeh M, Love-Jones S, Patel NK, Gu JW, Bains A, et al. Effects of rate on analgesia in kilohertz frequency spinal cord stimulation: results of the PROCO randomized controlled trial. Neuromodulation. 2018;21(1):67–76.
Paz-Solís J, Thomson S, Jain R, Chen L, Huertas I, Doan Q. Exploration of high- and low-frequency options for subperception spinal cord stimulation using neural dosing parameter relationships: the HALO study. Neuromodulation. 2022;25(1):94–102.
Sandkühler J. Models and mechanisms of hyperalgesia and allodynia. Physiol Rev. 2009;89(2):707–58.
Lee KY, Ratté S, Prescott SA. Excitatory neurons are more disinhibited than inhibitory neurons by chloride dysregulation in the spinal dorsal horn. eLife. 2019;8.
Gilbert JE, Titus N, Zhang T, Esteller R, Grill WM. Surround inhibition mediates pain relief by low amplitude spinal cord stimulation: modeling and measurement. eNeuro. 2022;9(5): ENEURO.0058-22.2022.
PubMed PubMed Central Google Scholar
Heijmans L, Zhang TC, Esteller R, Joosten EA. Ninety-Hz spinal cord stimulation-induced analgesia is dependent on active charge balance and is nonlinearly related to amplitude: a sham-controlled behavioral study in a rodent model of chronic neuropathic pain. Neuromodulation. 2024;27(1):95–107.
Metzger CS, Hammond MB, Paz-Solis JF, Newton WJ, Thomson SJ, Pei Y, et al. A novel fast-acting sub-perception spinal cord stimulation therapy enables rapid onset of analgesia in patients with chronic pain. Expert Rev Med Devices. 2021;18(3):299–306.
Anitescu M et al. Prospective, multicenter outcomes utilizing an SCS-system designed to engage surround inhibition using fast-acting sub-perception therapy [Abstract #75]. ASPN, session; Miami Beach, FL, USA; 2024.
Bayerl S, Paz-Solis J, Matis G, Rigoard P, Kallewaard JW, Canos-Verdecho MA, et al. Long-term outcomes using novel, fast-acting, sub-perception spinal cord stimulation therapy for chronic pain: a European, observational. Real-World Study J Clin Med. 2024;13:6999.
Metzger C, Hammond B, Ferro R, North J, Pyles S, Kranenburg A, et al. Two-year outcomes using fast-acting sub-perception therapy for spinal cord stimulation: results of a real-world multicenter study in the United States. Expert Rev Med Devices. 2025;22(2):155–64.
Chakravarthy K, Reddy R, Al-Kaisy A, Yearwood T, Grider J. A call to action toward optimizing the electrical dose received by neural targets in spinal cord stimulation therapy for neuropathic pain. J Pain Res. 2021;14:2767–76.
PubMed PubMed Central Google Scholar
Kumar K, Hunter G, Demeria D. Spinal cord stimulation in treatment of chronic benign pain: challenges in treatment planning and present status, a 22-year experience. Neurosurgery. 2006;58(3):481–96.
Deer TR, Mekhail N, Provenzano D, Pope J, Krames E, Thomson S, et al. The appropriate use of neurostimulation: avoidance and treatment of complications of neurostimulation therapies for the treatment of chronic pain. Neuromodulation Appropriateness Consensus Committee. Neuromodulation. 2014;17(6):571–97 (discussion 97-8).
Aiudi CM, Dunn RY, Burns SM, Roth SA, Opalacz A, Zhang Y, et al. Loss of efficacy to spinal cord stimulator therapy: clinical evidence and possible causes. Pain Physician. 2017;20(7):E1073–80.
Hayek SM, Veizi E, Hanes M. Treatment-limiting complications of percutaneous spinal cord stimulator implants: a review of eight years of experience from an academic center database. Neuromodulation. 2015;18(7):603–8 (discussion 8-9).
Hunter CW, Carlson J, Yang A, Patterson D, Lowry B, Mehta P, et al. BURST(able): a retrospective, multicenter study examining the impact of spinal cord stimulation with burst on pain and opioid consumption in the setting of salvage treatment and “upgrade.” Pain Physician. 2020;23(6):E643–58.
Van Buyten JP, Wille F, Smet I, Wensing C, Breel J, Karst E, et al. Therapy-related explants after spinal cord stimulation: results of an international retrospective chart review study. Neuromodulation. 2017;20(7):642–9.
PubMed PubMed Central Google Scholar
Pope JE, Deer TR, Falowski S, Provenzano D, Hanes M, Hayek SM, et al. Multicenter retrospective study of neurostimulation with exit of therapy by explant. Neuromodulation. 2017;20(6):543–52.
Patil AS, Levasseur B, Gupta M. Neuromodulation and habituation: a literature review and conceptional analysis of sustaining therapeutic efficacy and mitigating habituation. Biomedicines. 2024;12(5):930.
CAS PubMed PubMed Central Google Scholar
Hagedorn JM, Layno-Moses A, Sanders DT, Pak DJ, Bailey-Classen A, Sowder T. Overview of HF10 spinal cord stimulation for the treatment of chronic pain and an introduction to the Senza Omnia™ system. Pain Manag. 2020;10(6):367–76.
Lo Bianco G, Al-Kaisy A, Natoli S, Abd-Elsayed A, Matis G, Papa A, et al. Neuromodulation in chronic pain management: addressing persistent doubts in spinal cord stimulation. J Anesth Analg Crit Care. 2025;5(1):3.
PubMed PubMed Central Google Scholar
D'Souza RS, Her YF. Stimulation holiday rescues analgesia after habituation and loss of efficacy from 10-kilohertz dorsal column spinal cord stimulation. Reg Anesth Pain Med. 2022;47(12):722–27.
PubMed PubMed Central Google Scholar
North J, Loudermilk E, Lee A, Sachdeva H, Kaiafas D, Washabaugh E, et al. Outcomes of a multicenter, prospective, crossover, randomized controlled trial evaluating subperception spinal cord stimulation at ≤1.2 kHz in previously implanted subjects. Neuromodulation. 2020;23(1):102–8.
Andrade P, Heiden P, Visser-Vandewalle V, Matis G. 1.2 kHz high-frequency stimulation as a rescue therapy in patients with chronic pain refractory to conventional spinal cord stimulation. Neuromodulation. 2021;24(3):540–5.
Rigoard P, Billot M, Bougeard R, Llopis JE, Raoul S, Matis G, et al. Improved outcomes and therapy longevity after salvage using a novel spinal cord stimulation system for chronic pain: multicenter, observational, European case series. J Clin Med. 2024;13(4):1079.
PubMed PubMed Central Google Scholar
Rigoard P, Ounajim A, Goudman L, Banor T, Héroux F, Roulaud M, et al. The challenge of converting “failed spinal cord stimulation syndrome” back to clinical success, using SCS reprogramming as salvage therapy, through neurostimulation adapters combined with 3D-computerized pain mapping assessment: a real life retrospective study. J Clin Med. 2022;11(1):272.
PubMed PubMed Central Google Scholar
Reddy RD, Moheimani R, Yu GG, Chakravarthy KV. A review of clinical data on salvage therapy in spinal cord stimulation. Neuromodulation. 2020;23(5):562–71.
D’Souza RS, ElSaban M, Martinez Alvarez GA, Jin MY, Kubrova E, Hassett LC. Treatment of pain in length-dependent peripheral neuropathy with the use of spinal cord stimulation: a systematic review. Pain Med. 2023;24(Supplement_2):S24-s32.
Mekhail NA, Levy RM, Deer TR, Kapural L, Li S, Amirdelfan K, et al. ECAP-controlled closed-loop versus open-loop SCS for the treatment of chronic pain: 36-month results of the EVOKE blinded randomized clinical trial. Reg Anesth Pain Med. 2024;49(5):346–54.
Nijhuis H, Kallewaard JW, van de Minkelis J, Hofsté WJ, Elzinga L, Armstrong P, et al. Durability of evoked compound action potential (ECAP)-controlled, closed-loop spinal cord stimulation (SCS) in a real-world European chronic pain population. Pain Ther. 2024;13(5):1119–36.
PubMed PubMed Central Google Scholar
Pilitsis JG, Chakravarthy KV, Will AJ, Trutnau KC, Hageman KN, Dinsmoor DA, et al. The evoked compound action potential as a predictor for perception in chronic pain patients: tools for automatic spinal cord stimulator programming and control. Front Neurosci. 2021;15: 673998.
PubMed PubMed Central Google Scholar
Loudermilk E, Haddock A, Allavatam V, Shivacharan R, Esteller R. Analysis of ECAP detection levels and paresthesia-free spinal cord stimulation dose. north american neuromodulation society annual meeting, session "universal principles of the SCS therapeutic window: from mechanisms to clinical practice"; Orlando, FL, USA; Jan 31, 2025.
Mangano N, Torpey A, Devitt C, Wen GA, Doh C, Gupta A. Closed-loop spinal cord stimulation in chronic pain management: mechanisms, clinical evidence, and emerging perspectives. Biomedicines. 2025;13(5):1091.
Comments (0)